CD4+ memory T cells were significantly increased in patients treated with antiprogrammed death-1 (PD-1) antibody blockade [49] and their increased abundance in the tumor microenvironment predicted a benign prognosis for patients with gastric cancer [50]. This evidence concerns the gene CD4 and neoplasm.